600518.SS

Kangmei Pharmaceutical Co., Ltd. [600518.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600518.SS Stock Summary

In the News

600518.SS Financial details

Company Rating
Buy
Market Cap
26.2B
Income
-1.96B
Revenue
4.99B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
6.37K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
-13.27
Forward P/E
-
PEG
1.07
P/S
5.12
P/B
3.82
P/C
-
P/FCF
-12.85
Quick Ratio
0.78
Current Ratio
1.36
Debt / Equity
0.04
LT Debt / Equity
0.03
-
-
EPS (TTM)
-0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-133.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-24.52%
Revenue Q/Q
-6.16%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-4.66%
SMA100
-1.08%
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-28%
ROC
-0.17%
Gross Margin
15%
Oper. Margin
-32%
Profit Margin
-39%
Payout
-
Shs Outstand
13.86B
Shs Float
9.63B
-
-
-
-
Target Price
-
52W Range
1.68-2.5
52W High
-5.5%
52W Low
+89%
RSI
55.13
Rel Volume
1.02
Avg Volume
72.97M
Volume
74.44M
Perf Week
5%
Perf Month
0.53%
Perf Quarter
-
Perf Half Y
1.07%
-
-
-
-
Beta
0.694
-
-
Volatility
0.03%, 0.04%
Prev Close
0.53%
Price
1.89
Change
1.07%

600518.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.382.430.390.30.3
Net income per share
0.03-0.99-2.250.57-0.19
Operating cash flow per share
0.020.610.070.02-0.05
Free cash flow per share
-0.350.510.050-0.06
Cash per share
-0.13-0.69-0.210.170.11
Book value per share
2.14.36-0.760.710.49
Tangible book value per share
1.923.94-0.850.670.45
Share holders equity per share
2.14.36-0.760.710.49
Interest debt per share
2.57.472.410.090.02
Market cap
113.83B17.57B37.03B42.92B31.13B
Enterprise value
141.04B50B67.56B40.71B29.89B
P/E ratio
303.96-3.77-1.195.42-11.55
Price to sales ratio
6.671.536.8410.347.45
POCF ratio
372.466.135.9200.38-41.51
PFCF ratio
-26.557.2950.741.01K-39.01
P/B Ratio
4.380.86-3.514.324.48
PTB ratio
4.380.86-3.514.324.48
EV to sales
8.264.3712.489.87.15
Enterprise value over EBITDA
43.4-411.63-36.442.7-19.98
EV to operating cash flow
461.4917.3565.5190.05-39.85
EV to free cash flow
-32.8920.7692.59956.11-37.45
Earnings yield
0-0.26-0.840.18-0.09
Free cash flow yield
-0.040.140.020-0.03
Debt to equity
1.121.61-2.950.020.04
Debt to assets
0.40.510.930.010.02
Net debt to EBITDA
8.37-267.01-16.47-0.150.83
Current ratio
1.931.690.81.671.36
Interest coverage
0.37-0.47-0.8814.18-12.85
Income quality
0.83-0.62-0.040.030.28
Dividend Yield
0.030.140.0300
Payout ratio
8.05-0.55-0.0300
Sales general and administrative to revenue
0.020.020.070.050.04
Research and developement to revenue
0.010.01000.01
Intangibles to total assets
0.030.030.040.040.04
Capex to operating cash flow
-15.03-0.16-0.29-0.80.06
Capex to revenue
-0.27-0.04-0.06-0.04-0.01
Capex to depreciation
-9.18-0.68-0.48-0.28-0.13
Stock based compensation to revenue
00000
Graham number
1.29.846.213.031.45
ROIC
0.01-0.02-0.091.37-0.14
Return on tangible assets
0.01-0.07-0.970.52-0.19
Graham Net
-1.48-4.39-2.53-0.01-0.21
Working capital
26.42B19.19B-4.74B3.34B1.94B
Tangible asset value
23.71B18.54B-11.76B9.28B6.35B
Net current asset value
7.85B3.08B-25.19B2.2B-745.22M
Invested capital
1.121.61-2.950.020.04
Average receivables
15.16B16.24B13.1B7.14B2.76B
Average payables
2.68B3.51B3.77B2.89B2.29B
Average inventory
34.55B32.63B18.56B4.45B2.97B
Days sales outstanding
385.69460.42793.55221.07262.43
Days payables outstanding
102.07138.65262.73210.97263.78
Days of inventory on hand
1.06K1.15K398.68334.49283.05
Receivables turnover
0.950.790.461.651.39
Payables turnover
3.582.631.391.731.38
Inventory turnover
0.340.320.921.091.29
ROE
0.01-0.232.950.8-0.39
Capex per share
-0.37-0.1-0.02-0.010

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.070.10.090.080
Net income per share
-0.05-0.13000
Operating cash flow per share
-0.05-0.13000
Free cash flow per share
-0.05-0.13-0.0100
Cash per share
0.140.110.10.080
Book value per share
0.650.490.550.440
Tangible book value per share
0.60.450.50.410
Share holders equity per share
0.650.490.550.440
Interest debt per share
0.020.020.020.020
Market cap
25.21B31.13B26.34B30.58B0
Enterprise value
23.46B29.89B25.3B29.55B-916.21M
P/E ratio
-9.14-4.3-132.31-101.320
Price to sales ratio
26.7321.3523.0224.80
POCF ratio
-36.56-17.21-529.252.34K0
PFCF ratio
-36.11-16.89-337.5912.54K0
P/B Ratio
2.794.483.824.480
PTB ratio
2.794.483.824.480
EV to sales
24.8820.4922.1223.97-0.79
Enterprise value over EBITDA
-33.18-30-409.53-389.2412.48
EV to operating cash flow
-34.03-16.52-508.42.27K14.51
EV to free cash flow
-33.61-16.21-324.312.12K12.66
Earnings yield
-0.03-0.06000
Free cash flow yield
-0.03-0.06000
Debt to equity
0.030.040.040.040.04
Debt to assets
0.020.020.020.020.02
Net debt to EBITDA
2.471.2516.7913.5212.48
Current ratio
1.471.361.381.391.36
Interest coverage
-41.95-20.85-16.88-20.48-6.98
Income quality
11100
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.43-0.190.11-0.060.29
Research and developement to revenue
0.0100.010.010.01
Intangibles to total assets
0.040.040.040.040.04
Capex to operating cash flow
0.010.020.57-0.810.15
Capex to revenue
-0.01-0.02-0.02-0.01-0.01
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.851.190.220.220
ROIC
-0.01-0.2-0.01-0.010
Return on tangible assets
-0.05-0.120-0.010
Graham Net
-0.07-0.21-0.24-0.20
Working capital
2.56B1.94B1.97B1.95B1.87B
Tangible asset value
8.4B6.35B6.31B6.24B6.22B
Net current asset value
1.53B-745.22M-747.71M-758.69M-711.23M
Invested capital
0.030.040.040.040.04
Average receivables
2.62B2.78B3B2.89B2.8B
Average payables
2.01B2.31B2.41B2.18B2.17B
Average inventory
3.24B3.03B2.7B2.68B2.76B
Days sales outstanding
244.47185.48235.82203.7219.24
Days payables outstanding
239.11179.12206.19194.55204.86
Days of inventory on hand
385.3192.2242.47249.46259.91
Receivables turnover
0.370.490.380.440.41
Payables turnover
0.380.50.440.460.44
Inventory turnover
0.230.470.370.360.35
ROE
-0.08-0.26-0.01-0.010
Capex per share
00000

600518.SS Frequently Asked Questions

What is Kangmei Pharmaceutical Co., Ltd. stock symbol ?

Kangmei Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 600518.SS

What is Kangmei Pharmaceutical Co., Ltd. stock quote today ?

Kangmei Pharmaceutical Co., Ltd. stock price is $1.89 today.

Is Kangmei Pharmaceutical Co., Ltd. stock public?

Yes, Kangmei Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar